Back
CRISPR Therapeutics AG Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
46.26
Seasonality Move:
12.87%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...CRISPR Therapeutics AG Stock Forecast
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 20.7% based on the past 8 years of stock performance.
- CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is CRISPR Therapeutics AG Stock Undervalued?
The current CRISPR Therapeutics AG [CRSP] share price is $47.26. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 20.7% based on the past 8 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
- CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
91.10
52-Week Low:
43.42
Prediction Charts
Market Cap:
4.03B
Price in USD:
47.26
Volume:
1.94M
Beta:
1.99
Technical Analysis
SMA50:
47.94
SMA100:
49.79
SMA200:
57.34
52-Wk Change:
-34.52%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?
Yes, CRISPR Therapeutics AG is a publicly traded company. -
What is the CRISPR Therapeutics AG stock quote today?
The CRISPR Therapeutics AG stock price is 47.26 USD today. -
How to buy CRISPR Therapeutics AG stock online?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 46.96 | 50.76 | 50.85 | 46.91 |
| Nov-4 | 50.44 | 50.62 | 51.90 | 49.21 |
| Nov-5 | 49.35 | 50.36 | 50.42 | 47.04 |
| Nov-6 | 51.80 | 50.72 | 51.88 | 49.39 |
| Nov-7 | 51.40 | 51.88 | 53.26 | 51.15 |
| Nov-8 | 51.21 | 51.59 | 52.52 | 50.60 |
| Nov-11 | 53.13 | 54.86 | 59.07 | 53.00 |
| Nov-12 | 53.80 | 50.73 | 53.99 | 50.53 |
| Nov-13 | 50.90 | 49.79 | 52.43 | 49.41 |
| Nov-14 | 49.86 | 46.85 | 50.10 | 46.84 |
| Nov-15 | 47.61 | 47.25 | 48.44 | 46.30 |
| Nov-18 | 47.83 | 47.30 | 48.28 | 46.71 |
| Nov-19 | 46.97 | 46.97 | 47.53 | 46.56 |
| Nov-20 | 47.14 | 47.26 | 47.91 | 46.61 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.